VC  Oxford Bioscience Partners

     Office Locations:

12 Giles Place
Mansfield, MA 02048
Phone: 617-357-7474
Fax: 617-357-7476



  • Early
  • Expansion
  • Growth
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    Established in 1992, Oxford Bioscience Partners (OBP) is a life science venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. With approximately $1B of committed capital under management, OBP has invested in over 140 life science companies worldwide. OBP typically acts as the lead investor and makes investments between $1,000,000 and $10,000,000. OBP will also provide smaller seed capital investments in selective situations. OBP provides equity financing to companies at all stages, and will consider almost all geographic locations. OBP has also invested in non-life science based technologies which have novel healthcare applications. Additional offices are in Monroe, Connecticut and Malibu, California.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Alan Watson Ph.D., MBA Executive-in-Residence
    Andrea Costantino Vice President of Finance
    B. Christopher Kim Ph.D Partner
    Cornelius T. Ryan Founding General Partner
    Daniel Cole Venture Partner


    Portfolio companies include:

      ACADIA Pharmaceuticals
        web link

      Accelerated Holding
        web link

      Affinium Pharmaceuticals
        web link

      Alantos Pharmaceuticals
        web link

      Applied Spine Technologies
        web link

        web link

      Astex Therapeutics
        web link

      Avalon Pharmaceuticals
        web link

      AVEO Pharmaceuticals
        web link

        web link

      Cambrios Technologies
        web link

        web link

      Cardiome Pharma
        web link

        web link

      CGI Pharmaceuticals
        web link

        web link

      Claros Diagnostics
        web link

      Coherex Medical
        web link

      Concentric Medical
        web link

      Critical Therapeutics
        web link

      Decision Biomarkers
        web link

      Dicerna Pharmaceuticals
        web link

      Elixir Pharmaceuticals
        web link

      Enanta Pharmaceuticals
        web link

      Ensemble Therapeutics
        web link

        web link

      Gene Logic
        web link

      Genetic Therapy
        web link

        web link

      Genset SA
        web link

        web link

      Glori Energy
        web link

      Human Genome Sciences
        web link

        web link

        web link

      Inverness Medical Innovations
        web link

      Laboratory Partners
        web link

      Luca technologies
        web link

        web link

        web link

      Salix Pharmaceuticals
        web link

        web link

        web link

        web link


    Recent News: